Abstract. A variety of recent studies support the existence of pathways, in adult humans and rodents, that allow adult stem cells to be surprisingly flexible in their differentiation repertoires. Termed plasticity, this property allows adult stem cells, assumed until now to be committed to generating a fixed range of progeny, on relocation to switch to make other specialized sets of cells appropriate to their new niche. Cells normally present within the bone marrow seem particularly flexible and are able to contribute usefully to many recipient organs.
Abstract. A variety of recent studies support the existence of pathways, in adult humans and rodents, that allow adult stem cells to be surprisingly flexible in their differentiation repertoires. Termed plasticity, this property allows adult stem cells, assumed until now to be committed to generating a fixed range of progeny, on relocation to switch to make other specialized sets of cells appropriate to their new niche. Cells normally present within the bone marrow seem particularly flexible and are able to contribute usefully to many recipient organs. In studies of the liver, bone marrow-derived cells are seen with specialized structural and metabolic adaptations commensurate with their new locations, and these may be abundant, even sufficient, to rescue recipient mice from genetic defects and with evidence that they have proliferated in situ. In the kidney, several studies provide evidence for the presence of "reprogrammed" cells, but in most, it remains possible that cells arrive and redifferentiate but are no longer stem cells. Nevertheless, that appropriately differentiated cells are delivered deep within organs simply by injection of bone marrow cells should make us think differently about the way organs regenerate and repair. Migratory pathways for multipotential cells could be exploited to effect repairs using an individual's own stem cells, perhaps after gene therapy. This concept makes it clear that a transplanted organ would in time become affected by the genetic susceptibilities of the recipient, because of phenotypes that are expressed when trafficking cells incorporate and differentiate. Some 30 yr ago, it was suggested that there were probably circulating endothelial precursor cells, derived from the bone marrow that contributed to the repair of renal vessels after transplantation (1), yet until recently it had not been appreciated that bone marrow contributed a variety of cells to tissues in several organs. This contribution has become recognized with the advent of robust methods for tracking cell lineage in routine histology specimens.
In adult organisms, each tissue and organ is generally accepted to contain a small subpopulation of cells capable of self-maintenance, of indefinite proliferative potential and with the ability to give rise to a large family of descendants with defined spectra of specialization (multipotential stem cells) (2) (3) (4) (5) (6) . The location of the stem cell compartment(s) in the adult kidney is not clearly defined. In kidney development, it is recognized that single metanephric mesenchymal stem cells can generate all of the epithelial cell types of the nephron (other than those of the collecting ducts), but it is unknown whether such stem cells persist in adult life (7) . Experiments seeking label-retaining cells and proliferative compartments suggest that in the glomerulus, the most frequently labeled cells were endothelial and that the epithelia lining Bowman's capsule were labeled more often than cells in the tuft, with podocytes almost never labeled (8) .
The adult mammalian kidney has some ability to repair. Tubular cells can divide and tubules may regenerate after injury, which may involve epithelial-mesenchymal transition (EMT; outlined below). In addition, it now seems that the bone marrow acts as a renal stem cell compartment. Bone marrow has recently been recognized as a third stem cell compartment for the liver, after hepatocytes and cholangiocytes (9 -12) . Perhaps the "normal" physical separation of hematopoiesis from renal function in adult mammals prevents the generation of new nephrons, whereas in some fish, hematopoiesis occurs in the kidney and new nephrons can be formed (13) . restored by endothelial continuity from surviving donor endothelial cells (14) . More recently, Lagaaij et al. (15) suggested that the extent of replacement of endothelial cells lining small renal vessels was related to the severity of vascular rejection, as six of seven grafts affected by vascular rejection showed Ͼ33% recipient-derived endothelial cells, whereas just 2 of 13 patients without evidence of rejection showed an extensive endothelial recolonization. We have seen occasional male endothelial cells in female renal allografts but had focused on epithelium (16 (17) found no recipient endothelium; only in the mouse is there firm evidence that whole bone marrow contributes to glomerular endothelium (18) .
Epithelial Mesenchymal Transitions and Renal Repair
In the kidney an EMT between the phenotype of epithelial cells and fibroblasts (both being generated originally from the primitive metanephric mesenchyme) is seen as a response to a breach of the tubular basement membrane (19) . In various models, epithelial cells are seen to acquire markers of fibroblasts or myofibroblasts and adopt a fusiform morphology; in interstitial fibrosis, cells are seen with a fibroblastic morphology, yet they bear epithelial markers. Key effector molecules in EMT are TGF-␤1, EGF, and fibroblast growth factor-2 (20 -22) , with the extracellular matrix also affecting cell phenotype (23) . EMT seems restricted to regions where the basement membrane is damaged, with the cells most myofibroblastic in phenotype seen where the tubular basement membrane was extensively damaged (24) . These observations and others on cultured cells are concordant with the hypothesis that the epithelium adopts a fibroblastic morphology before proliferating and perhaps before helping to repair the basement membrane. Sun et al. (25) examined rat kidneys after uranyl acetate induced tubular necrosis and considered that repair occurred without movement of cells from the interstitium into the denuded tubules, yet they observed proliferation of flattened cells lining the regenerating tubules that expressed vimentin, like myofibroblasts.
A broader hypothesis is that the EMT process is reversible, with some of the myofibroblasts being of extrarenal, perhaps normally bone marrow in origin. There is some support for this view. Transplantation of male whole bone marrow into female recipients is followed in the small and large intestine by progressive conversion (to male) of most of the smooth muscle actin-expressing myofibroblast population surrounding the crypts (26) .
In our studies of whole bone marrow transplants in mice, we observed marrow-derived interstitial cells and renal tubular epithelial cells (16) . As illustrated in Figure 1 , these were in general scattered in tubules, although small clusters did occur. In human renal transplants in which female kidneys were grafted into male recipients, we noted male tubular cells expressing the epithelial marker CAM 5.2 (16) . A bone marrow contribution to renal tubular epithelium has also been reported, in abstract form, by Lin et al. (27) , who used ␤-galactosidase as a marker of origin.
Considering glomeruli, we have described marrow-derived cells that seemed to be podocytes (16) , based on their location and immunoreactivity for vimentin. As illustrated in Figure 1 , these cells were seen to have a brown-stained Y chromosome within a nucleus located in a vimentin-positive cell. An additional strand of evidence is presented in Figure 2 , in which dual fluorescence in situ hybridization for X and Y chromosomes has been carried out on a histologic section of human female kidney that had been transplanted into a male recipient. The vast majority of assessable cells were female (two greenfluorescent X chromosomes). More detailed examination of a region of the glomerulus shown revealed two cells apparently with pairs of X and Y chromosomes; this region was scanned serially in the z-axis and a "panorama" of 64 slices generated to help visualize the arrangement of signals more clearly. This process indicated that there are indeed cells at the periphery of the glomerular tuft with 2 X and 2 Y. One possibility is that these are nuclei of male podocytes; binucleate podocytes have been reported in 6 of 164 cases of diseased human kidney, although mitotic podocytes are very rare (28) . The possibility that these nuclei result from fusion or imminent division of two male cells (both XY) cannot be excluded at this stage.
Grimm et al. (29) also reported evidence for host-derived mesenchymal cells in renal transplants that were experiencing chronic rejection, but did not describe the generation of tubular cells. Andersen et al. (17) noted that tubular and glomerular cells remained of donor origin in transplanted kidneys even 10 mo after transplantation, and no donor-derived renal tubular epithelial cells were seen in any of the 5 mice grafted by Krause et al. (30) , perhaps as a result of the use of sorted hematopoietic stem cells rather than whole marrow cells.
Bone Marrow Contribution to the Glomerular Mesangium
Studies using enhanced green fluorescence protein (eGFP)-transgenic rats revealed that the bone marrow makes a significant long-term contribution to the mesangial cell population (31) . In mice, one of the most significant reports of bone marrow-derived cells contributing to renal repair is that of Cornacchia et al. (18) , who demonstrated that bone marrow from mice with an inherited glomerular mesangial sclerosing defect transferred the disease phenotype; the morphology and matrix metalloproteinase expression levels were due to generation of endothelial and mesangial cells from the donor bone marrow. Another study revealing that bone marrow-derived cells can affect the progression of renal disease is that of Yokoo et al. (32) , who used engineered bone marrow to deliver to the glomerulus cells expressing a gene that reduced susceptibility to experimental Goodpasture syndrome, although they did not seek to establish whether any "plasticity" had occurred.
Which Bone Marrow Cells Contribute to Renal Repair?
Adult bone marrow contains hematopoietic stem cells (HSC) and mesenchymal stem cells (MSC), which may derive from a common primitive blast-like cell precursor able to differentiate along MSC or HSC potentials (33) . These two populations both are viable when whole bone marrow is aspirated and immediately transplanted by injection intravenously into recipient irradiated mice, yet they are seen to have different potentials; MSC isolated by adhesion to plastic or other means are able to contribute to bone, cartilage, and cardiac muscle but not to blood or liver, whereas HSC isolated by cell sorting can contribute to liver and cardiac muscle and vasculature (see review (34) ).
It is unclear whether HSC or MSC or both are responsible for the cellular progeny found in the kidney after transplantation of whole bone marrow, although sorted HSC were reported to be able to contribute to tubular epithelium (27) . It is also not known in renal transplantation whether the recipient cells that engraft are derived from bone marrow or other circulating populations. 
What Factors Affect Engraftment?
The ability of a cell to act as a stem cell is regulated to a considerable extent by the environment forming the niche where it resides (35) . In the development of melanocytes, for example, it seems that melanoblasts (generally considered to be committed precursors and no longer stem cells), when given the opportunity to occupy vacant niches, revert to a stem cell state (36) . Niches may be defined by a combination of matrixbound and soluble factors that can be altered experimentally. Factors present within a cell line-conditioned medium regulate the programming of early primitive ectoderm-like cells, significantly changing the repertoire of differentiation possible from these cells in a reversible way (37) . Adult mouse neural stem cells injected into an early embryo contribute to the developing kidney (38) , so adult stem cells may be reprogrammed to differentiate into renal cells. Thus, it may be a reasonable hypothesis that circulating stem cells occupy tissue-specific niches vacated after damage and then adopt the lineage restriction appropriate to their new environment. Whether this engraftment or subsequent expansion could be modified by exogenous growth factors needs to be tested. One candidate is hepatocyte growth factor, which has been shown to offer renal protection in allograft nephropathy in rats (39) and is also recognized as an agent involved in the differentiation of metanephric mesenchymal cells into epithelial precursors of the nephrons (40).
In the kidney, there is no recognizable stem cell zone and therefore no pattern of replacement possible to recognize that would establish that engrafted cells are operating now as local stem cells, rather than isolated reprogrammed cells. What would be useful is a mechanism to reveal clonal expansion, whereby progeny of individual cells could be recognized. Demonstration of this would, ideally, require the isolation and transplantation of single cells that self-renew and produce a family of descendants that eventually become fully functional; these robust criteria have been met for the liver, in a model in which the progeny had a selective advantage (41) . However, some commentators have added that this phenomenon should be shown to occur "naturally" in organs, not forced to undergo organ degeneration before accepting that stem cells jump a lineage boundary (42) . Clearly, it is difficult to track cells without intervention, and most of the studies to date involve damage consequent on ablation of bone marrow by irradiation or chemical means or the traumas of surgery and rejection, whereby organs have been transplanted then studied some time later.
A counter argument is that a degree of organ damage is essential to allow transdifferentiation or stem cell plasticity to take place at recognizable levels. Kleeberger et al. (43) found that cholangiocyte differentiation occurred earlier and more frequently than hepatocyte differentiation from circulating cells and that hepatocytes were formed more commonly when there was recurrent hepatitis. They used an elegant laser capture microdissection/PCR amplification method to establish whether specific cells were of donor or recipient origin. It may be that migration of bone marrow stem cells throughout the body acts essentially as a back-up system, able in extremis to augment an organ's intrinsic regenerative capacity.
Proof of Origin?
The origin of cells seems clear in studies in which whole or sorted bone marrow cells have been transplanted and a marker such as eGFP or ␤-galactosidase has been used for lineage tracing, but what of studies in which female organs have been examined at times after transplantation into male recipients and the Y chromosome has been used as a lineage marker? Transfer of fetal cells across the placenta does occur (e.g., (44)), and long-term male microchimerism of blood mononuclear cells is recognized (45) . So might the male cells recognized in female allografts be from earlier pregnancies. In some studies of liver engraftment, this mechanism has been considered and excluded (9, 43) , but it remains a possibility for the kidney.
Stem Cell Plasticity, Transdifferentiation, or Fusion Confusion?
Earlier this year, concerns were raised that the methods used to show that certain adult stem cells, particularly from the bone marrow and central nervous system, can jump lineage boundaries may be flawed, e.g., if reliance had been placed solely on the appearance of Y chromosome-positive cells in a female recipient or even if markers such as ␤-galactosidase or GFP had been used. Two publications suggested that the development of seemingly normal differentiated cells expressing a new marker might simply be due to the fusion of bone marrow cells with preexisting differentiated cells in the host's organs (46, 47) . Cell fusion events were shown to be possible, but at very low frequency (~1:100,000 cells) in tissue culture systems, not in vivo. Furthermore, the possibility that fusions (or heterokaryons) account for all instances of transdifferentiation or plasticity is at odds with a number of observations:
1. When highly purified hematopoietic stem cells from male Rosa26 bone marrow were used to rescue female mice deficient in fumaryl acetoacetate hydrolase (41) , discrete nodules of ␤-galactosidase-positive liver tissue formed in the liver. The nodules had normal histology and were not teratoma-like (as seen after fusion events (46)).
2. The thyroid of women with thyroid disease frequently contain male cells of presumed fetal origin, yet these were seen to possess just one X and one Y chromosome (48) , rather than the XXXY predicted initially after fusion.
3. Hematopoietic stem cells are abundant in cord blood and are found in peripheral blood, especially after exercise: if fusion events were common and without disadvantage, then we all should have large numbers of polyploid cells in many organs. This has not been reported outside the liver, where polyploidization does occur on a large scale-as a result of binucleate cells segregating on the same mitotic spindle.
4. Therapeutic grafting of female patients with G-CSFmobilized peripheral blood stem cells from male donors produced a variety of male cells, including new hepatocytes in the liver, but all those shown had one X and one Y chromosome (49) . Until studies show that heterokaryon formation actually occurs when adult stem cells "transdifferentiate" in vivo, extrapolations from rare events involving cultured embryonic stem cells are premature.
Conclusions
There is now a large body of evidence indicating that organspecific stem cell populations need not rely entirely on their own resources for maintenance and repair. Perhaps a key factor in the generation of self-renewing clones in the new tissues is the exposure to-and successful occupation of-niches emptied by damage, with the local environment of the niche defining the cell repertoire that will be produced.
Extraordinary claims require extraordinary proof, and some have asked for a higher standard of evidence; requiring "a clonal approach" (50) or demonstration of "a robust, sustained multi-lineage engraftment and functional activity representative of multiple phenotypic characteristics of the converted cells to show that full conversion has occurred" (42) . These criteria, put simply, are needed because showing partial repopulation of an organ with cells that have come to resemble their neighbors is not the same as showing a functional competence as diverse and broad as that expected of the indigenous population, yet this is what will be needed for tissue regeneration and for gene therapy strategies that rely on adult stem cell plasticity. We will need clonal expansion to yield all of the cell types normally produced, and only those, together with appropriate responses to the usual demands of growth, adaptation, and repair. So far, the experiments of Lagasse et al. (41, 51) are closest to answering all criticisms, yet researchers who are working on other organs have shown transplanted bone marrow cells to effect a degree of rescue from or transfer of pathology in bones (52) , skeletal muscle (53), central nervous system (54) , and kidney (18) . From a practical point of view, therapies may be possible soon, but understanding the risks will take longer.
